Los Angeles Times

SEP. 14, 2020


 WASHINGTON — One of the world’s largest drug companies has been aggressively raising prices even as it received hundreds of millions of dollars of U.S. government aid to develop a COVID-19 vaccine.
AstraZeneca, which the Trump administration has lauded for its vaccine work, boosted prices despite renewed promises by President Trump this summer to keep drug costs in check.


Read More

Mens Health

August 5, 2020


There’s no shortage of excuses that people give for not wearing a face mask while exercising during the Coronavirus pandemic: Face masks are cumbersome, they’re uncomfortable, and they make it hard to breathe. Many people have even subscribed to the myth that masks actually deplete oxygen levels while working out. But Tom Lawton, an ICU doctor from the United Kingdom, recently disproved that theory by testing it out himself—all while nearly completing a marathon.

Read More

New York Times
 July 27, 2020


The first large study of the safety and effectiveness of a coronavirus vaccine in the United States began on Monday morning, according to the National Institutes of Health and the biotech company Moderna, which collaborated to develop the vaccine.

Read More

Seeking Alpha
March 4, 2020


Citing a need to strengthen the existing warning about the risk of neuropsychiatric events associated with the drug, the FDA is now requiring a boxed warning in the labeling of Merck’s (MRK +4.6%) asthma med Singulair (montelukast sodium) and generic versions of the leukotriene receptor antagonist.

The agency says the precise incidence of said events is unknown but there have been reports of serious cases. It is also requiring a new medication guide to be given to patients with each prescription.

Read More

The New Your Times
March 9, 2020


As the coronavirus gained a foothold in the United States this weekend, thousands of employees from Seattle to Silicon Valley were told to work from home. Public school districts in several states have shut down, universities are moving classes to online only, and even churches are limiting services or prayer meetings.

As the coronavirus spread to two-thirds of the states, Americans began to grasp the magnitude of the threat facing them. The weekend’s case tally ballooned, veering toward nearly 600 cases and close to 20 deaths.

Read More

March  6th 2020


Just a week ago, the first “community spread” of the new coronavirus (COVID-19) was detected in the United States: a woman in Northern California who hadn’t been exposed to anyone known to have the virus.

Before her diagnosis, people in the United States were only thought to be at risk for COVID-19 if they had recently traveled to a high-risk area abroad or been exposed to someone who was sick.

But the woman in California hadn’t traveled internationally, nor had she been in contact with anyone with the infection.

This suggests that person-to-person transmission may be more likely than we originally anticipated.

Read More

New York Times, 
March 3th,  2020 



With the Coronavirus continuing to spread to more countries on Tuesday and epidemics in Iran, Italy and South Korea showing no signs of slowing, governments worked to devise plans to combat the pathogen without causing widespread social disruption and economic upheaval.


Read More

January  22th 2020


A local congressman is fighting to lower prescription drugs for American families.

“My fear is that I won’t be able to afford it,” said Chris Burrows, diabetes patient.


For diabetics, like Burrows, a vial of insulin could mean life or death. But skyrocketing prices could impact who gets it and who doesn’t.

Burrows attended a roundtable discussion hosted by Congressman Dan Kildee on Tuesday to voice his concerns.

Read More

Jan 12th 2020

The prices of more than 500 prescription drugs has risen since Jan. 1. The average price hike is about 5 percent. Among the drug prices that have increased are Cotempla XR, Eliquis, Truvada, and Humira. Read on to learn more about these and what you should know as an educated consumer in today’s world.



Read More

December 23th, 2019



The administration is issuing a proposed rule, along with a proposed guidance for the drug industry, that will allow states, pharmacies, wholesalers and manufacturers to import prescription drugs if they meet conditions designed to ensure that the importation poses no additional risk to safety and will save consumers money.


Read More


December 19th, 2019

The proposal is still a long way from being finalized, and many expensive drugs, like insulin, would be excluded from state plans.The decision is an unusual one for a Republican administration. Progressives have long supported such a policy, but the pharmaceutical industry vehemently opposed drug imports by claiming they were unsafe. Food and Drug Administration commissioners had also opposed importing drugs intended for overseas use, citing safety issues.

Read More